Clinical trial
A Prospective Multicenter Randomized Post Market All-comer Trial to Assess the Safety and Effectiveness of the SUPRAFLEX Sirolimus-eluting Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
NCT02870140 is registered in ClinicalTrials.gov with ECRI bv as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Multicenter Randomized Post Market All-comer Trial to Assess the Safety and Effectiveness of the SUPRAFLEX Sirolimus-eluting Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
- Lead sponsor
- ECRI bv
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 21, 2016
- Completion date
- August 26, 2020
- Enrollment
- 1,435 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.